Blastic Plasmacytoid Dendritic Cell Neoplasm.
Jain A, Sweet K.
J Natl Compr Canc Netw. 2023 May;21(5):515-521. doi: 10.6004/jnccn.2023.7026.
Plasmacytoid dendritic cell neoplasms.
Lee YJ, Kim Y, Park SH, Jo JC.
Blood Res. 2023 Apr 30;58(S1):90-95. doi: 10.5045/br.2023.2023052.
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
Xiao W, Chan A, Waarts MR, Mishra T, Liu Y, Cai SF, Yao J, Gao Q, Bowman RL, Koche RP, Csete IS, DelGaudio NL, Derkach A, Baik J, Yanis S, Famulare CA, Patel M, Arcila ME, Stahl M, Rampal RK, Tallman MS, Zhang Y, Dogan A, Goldberg AD, Roshal M, Levine RL.
Blood. 2021 Mar 11;137(10):1377-1391. doi: 10.1182/blood.2020007897.
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies.
Cuglievan B, Connors J, He J, Khazal S, Yedururi S, Dai J, Garces S, Quesada AE, Roth M, Garcia M, McCall D, Gibson A, Ragoonanan D, Petropoulos D, Tewari P, Nunez C, Mahadeo KM, Tasian SK, Lamble AJ, Pawlowska A, Hammond D, Maiti A, Haddad FG, Senapati J, Daver N, Gangat N, Konopleva M, Meshinchi S, Pemmaraju N.
Leukemia. 2023 Sep;37(9):1767-1778. doi: 10.1038/s41375-023-01968-z. Epub 2023 Jul 14.
CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm.
Pelosi E, Castelli G, Testa U.
Int J Mol Sci. 2023 Feb 1;24(3):2718. doi: 10.3390/ijms24032718.
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
Pollyea DA, Altman JK, Assi R, Bixby D, Fathi AT, Foran JM, Gojo I, Hall AC, Jonas BA, Kishtagari A, Lancet J, Maness L, Mangan J, Mannis G, Marcucci G, Mims A, Moriarty K, Mustafa Ali M, Neff J, Nejati R, Olin R, Percival ME, Perl A, Przespolewski A, Rao D, Ravandi F, Shallis R, Shami PJ, Stein E, Stone RM, Sweet K, Thota S, Uy G, Vachhani P, Cassara CJ, Freedman-Cass DA, Stehman K.
J Natl Compr Canc Netw. 2023 May;21(5):503-513. doi: 10.6004/jnccn.2023.0025.
Blastic Plasmacytoid Dendritic Cell Neoplasm.
Khoury JD.
Curr Hematol Malig Rep. 2018 Dec;13(6):477-483. doi: 10.1007/s11899-018-0489-z.
How I treat blastic plasmacytoid dendritic cell neoplasm.
Kharfan-Dabaja MA, Lane AA, Pemmaraju N.
Blood. 2025 Feb 6;145(6):567-576. doi: 10.1182/blood.2024024262.
Blastic Plasmacytoid Dendritic Cell Neoplasm in Children.
Li Y, Sun V, Sun W, Pawlowska A.
Hematol Oncol Clin North Am. 2020 Jun;34(3):601-612. doi: 10.1016/j.hoc.2020.01.008. Epub 2020 Mar 9.
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Pemmaraju N, Kantarjian H, Sweet K, Wang E, Senapati J, Wilson NR, Konopleva M, Frankel AE, Gupta V, Mesa R, Ulrickson M, Gorak E, Bhatia S, Budak-Alpdogan T, Mason J, Garcia-Romero MT, Lopez-Santiago N, Cesarman-Maus G, Vachhani P, Lee S, Bhatt VR, Blum W, Walter RB, Bixby D, Gojo I, Duvic M, Rampal RK, de Lima M, Foran J, Fathi AT, Hall AC, Jacoby MA, Lancet J, Mannis G, Stein AS, Mims A, Rizzieri D, Olin R, Perl A, Schiller G, Shami P, Stone RM, Strickland S, Wieduwilt MJ, Daver N, Ravandi F, Vasu S, Guzman M, Roboz GJ, Khoury J, Qazilbash M, Aung PP, Cuglievan B, Madanat Y, Kharfan-Dabaja MA, Pawlowska A, Taylor J, Tallman M, Dhakal P, Lane AA.
Blood. 2023 Feb 9;141(6):567-578. doi: 10.1182/blood.2022017865.
